Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone Iodine Swab vs Oral Antibiotics for SSI in Mohs Surgery
NCT06207786Withdrawn
- Sponsor
- Mayo Clinic
- Start
- Sep 2024
- Primary completion
- May 2029
- Modality
- Small Molecules
01
Overview
Randomised, open-label trial of povidone-iodine in surgical site infection (SSI) (2 arms), sponsored by Mayo Clinic. Primary endpoint: Effectiveness of nasal decolonization with povidone-iodine versus a standardized oral antibiotic prophylaxis protocol to prevent surgical site infection (SSI) at 30 days. Planned start Sep 2024; status: withdrawn.
02
Drugs
povidone-iodine
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT06207786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06207786.